Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
123.65
-2.24 (-1.78%)
Streaming Delayed Price
Updated: 11:02 AM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Merck & Co
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
87
88
Next >
AstraZeneca Q4 Earnings Beat, Sales Hurt By COVID Jab
February 09, 2023
Core earnings of $1.38 per share declined 17% year over year on a reported basis and 5% at constant exchange rates (CER).
Via
Talk Markets
Analyst Reiterates This Alzheimer's Candidate As Top Idea For 2023
February 08, 2023
Via
Benzinga
A Look At Pharma ETFs Post Q4 Earnings
February 08, 2023
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. However, solid earnings failed to fully impress pharma ETFs over the past month.
Via
Talk Markets
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,000 Today
February 08, 2023
Via
Benzinga
2 Top Biotech Stocks to Buy in February
February 08, 2023
Biotech stocks aren't all created equal -- these two are the best of the bunch.
Via
The Motley Fool
Should Investors Buy or Sell the Vaccinex Patent News?
February 07, 2023
Shares of Vaccinex, Inc. are higher on February 7 on news that the clinical-stage biotechnology company secured a patent. Is it time to buy or sell the news?
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Merck (MRK) Q4 2022 Earnings Call Transcript
February 02, 2023
MRK earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Merck Beats Earnings Estimates
February 02, 2023
Merck came out with quarterly earnings of $1.62 per share.
Via
Talk Markets
Merck's 2023 Earnings Guidance Widely Missed; Shares Slide
February 02, 2023
The sales outlook, on the other hand, was in line with forecasts.
Via
Investor's Business Daily
Is Merck Stock a Buy After Its Post-Earnings Sell-Off?
February 07, 2023
Despite beating analysts’ expectations on the top and bottom lines, MRK stock fell after earnings. This article analyzes if investors should jump in
Via
MarketBeat
Analyst Upgrades Personalis; Says Biopharma Is Strong, Cash Burn Is Down
February 06, 2023
Via
Benzinga
The 7 Most Undervalued Blue-Chip Stocks to Buy in February 2023
February 05, 2023
If you're looking for undervalued blue-chip stocks, we've come up with a list of seven stocks that you can consider adding.
Via
InvestorPlace
Market Rally Powers Higher On Tame Fed, Meta Earnings; Apple, Google, Amazon In Focus: Weekly Review
February 03, 2023
The major indexes continued to run despite mixed-to-weak earnings.
Via
Investor's Business Daily
Merck Beats On Q4 earnings, Anticipates Almost 80% Decline In COVID-19 Treatment Sales In 2023
February 02, 2023
Via
Benzinga
Merck & Co Earnings Preview
February 01, 2023
Via
Benzinga
Why Personalis Shares Are Trading Higher Today
February 03, 2023
Via
Benzinga
Merck's Keytruda Plus Chemo Combo Aces Late-Stage Study In Advanced Endometrial Cancer Patients
February 03, 2023
Via
Benzinga
Merck's Oral COVID-19 Treatment Might Be Linked To Spreading Mutations, Study Shows
February 03, 2023
According to some researchers, Merck & Co’s (NYSE: MRK) COVID-pill is giving rise to new mutations of the COVID-19 virus in some patients.
Via
Benzinga
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Therapy for Advanced or Recurrent Endometrial Carcinoma
February 03, 2023
From
Merck & Co., Inc.
Via
Business Wire
Checking In With Merck Stock Before Earnings
February 01, 2023
Merck will report earnings before the open Thursday, Feb. 2.
Via
Talk Markets
The 7 Most Undervalued Dow Stocks to Buy in February 2023
February 02, 2023
If you’re looking for the best deals among the most iconic enterprises, these are the most undervalued Dow stocks to buy.
Via
InvestorPlace
Why These 2 Stocks Made the Dow Miss the Market Rally
February 02, 2023
Even as the S&P 500 climbed, weaker performance from Dow components held the average back.
Via
The Motley Fool
US Stocks Higher, NASDAQ Adds Over 230 Points
February 02, 2023
US stocks traded higher this morning, with the NASDAQ gaining more than 230 points on Thursday. Following the market opening Thursday, the Dow traded up 0.02% to 34,092.96, while the NASDAQ rose 2.00%...
Via
Benzinga
Got $5,000? 3 Stocks to Hold for the Next 20 Years
February 02, 2023
Not every company is built to thrive -- or even survive -- for the long haul. These are.
Via
The Motley Fool
Nasdaq Futures Fly As Meta Keeps Tech Earnings' Buoyancy Intact: Will Apple, Amazon, Alphabet Toe In Line?
February 02, 2023
The index futures point to a mixed opening on Thursday, as tech earnings continue to be encouraging.
Via
Benzinga
Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results
February 02, 2023
From
Merck & Co., Inc.
Via
Business Wire
3 No-Brainer Dividend Stocks to Buy Hand Over Fist in 2023
February 01, 2023
These healthcare titans are poised for a strong showing in 2023 and beyond.
Via
The Motley Fool
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
January 31, 2023
The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new...
Via
Benzinga
7 Healthcare Stocks That Will Be Big Winners in 2023
January 31, 2023
Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider.
Via
InvestorPlace
Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January
January 30, 2023
Biotech stocks are off to a great start in 2023 with the IBB up 4.5% and the XBI up 7.7%.
Via
Talk Markets
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
87
88
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.